MedElevator Войти в исследования
← Поиск публикаций

DOI 10.18926/amo/53996

Медицинская библиотека · Acta medica Okayama · 2016

Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.

Yasunaka Tetsuya, Ikeda Fusao, Wada Nozomu, Morimoto Yuki, Fujioka Shin-ichi, Toshimori Junichi, Kobashi Haruhiko, Kariyama Kazuya, Morimoto Yoichi, Takayama Hiroki, Seno Tomonori, Takaguchi Koichi, Moriya Akio, Miyatake Hirokazu, Okamoto Ryoichi, Yabushita Kazuhisa, Takaki Akinobu, Yamamoto Kazuhide

Сравнительное исследованиеСтатьяПеревод пока не подготовлен

Аннотация

Chronic hepatitis B (CHB) leads to cirrhosis and hepatocellular carcinoma (HCC). With a cohort of 1,206 CHB patients who visited Okayama University Hospital and related hospitals in 2011 and 2012, we compared the incidence rates of HCC among the patients grouped by age, hepatitis B virus (HBV) DNA, hepatitis B e antigen (HBeAg), and treatment. HCCs were observed in 115 patients with the median observation period of 1,687 days. Among the HCC patients aged > 35 years, HBV DNA > 4 log copies/mL and positive HBeAg at diagnosis (n=184), the HCC incidence rate was 8.4% at 5 years in the entecavir (ETV)-treated patients, 21.8% in the lamivudine (LVD)-treated patients, and 26.4% among the patients not treated with drugs. The cumulative HCC incidence was significantly reduced in the ETV-treated patients compared to those treated with LVD or not treated (p=0.013). Among the patients aged >35 years with HBV DNA > 4 log copies/mL and negative HBeAg (n=237), the cumulative HCC incidence was 14.6% in 5 years in ETV group and 13.9% among those not treated with a drug (p>0.05). Only small numbers of HCCs occurred in other patients. In CHB patients aged > 35 years with HBV DNA > 4 log copies/mL and positive HBeAg, ETV treatment is recommended for the suppression of HCC development.

Для цитирования: Yasunaka Tetsuya, Ikeda Fusao, Wada Nozomu, Morimoto Yuki, Fujioka Shin-ichi, Toshimori Junichi, Kobashi Haruhiko, Kariyama Kazuya, Morimoto Yoichi, Takayama Hiroki, Seno Tomonori, Takaguchi Koichi, Moriya Akio, Miyatake Hirokazu, Okamoto Ryoichi, Yabushita Kazuhisa, Takaki Akinobu, Yamamoto Kazuhide. Entecavir Reduces Hepatocarcinogenesis in Chronic Hepatitis B Patients.. Acta medica Okayama. 2016. DOI: 10.18926/amo/53996.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.